ELI LILLY & Co (LLY) Stock Analysis
HealthcarePharmaceutical Preparations
Q1 2026 · +55.5% revenue · +2.6% revenue
Beat the trendvs trailing 3-quarter avg
Revenue▲+10.9 ppvs trend
Net income▼−37.5 ppvs trend
Diluted EPS▼−37.9 ppvs trend
Outperformed in 1 of 3 metrics
How the cash was deployedQ1 2026
Operating cash flow$5.33B
Share buybacks$2.36B (44.2 %)
Dividends paid$1.55B (29.0 %)
Debt repayment$750.00M (14.1 %)
Returned to shareholders this quarter$3.90B▲ +53.3%
Last 8 quarters of revenueLatest quarter highlighted. Q4 reconstructed from the annual filing.
+55.5% +2.6%
11.30BQ2 24
11.44BQ3 24
13.53BQ4 24*
12.73BQ1 25
15.56BQ2 25
17.60BQ3 25
19.29BQ4 25*
19.80BQ1 26
* Q4 is reconstructed from the annual filing (FY − Q1 − Q2 − Q3), since the SEC does not require a Q4 10-Q.
RevenueSlowing
$19.80B▲+55.5% ▲+2.6%
9.35B
8.77B
11.30B
11.44B
13.53B
12.73B
15.56B
17.60B
19.29B
19.80B
Net incomeSlowing
$7.40B▲+168% ▲+11.4%
2.19B
2.24B
2.97B
970.30M
4.41B
2.76B
5.66B
5.58B
6.64B
7.40B
Free cash flowNot enough history
—— —
Not enough quarters yet to read the trend.Diluted Slowing
$8.26▲+170% ▲+11.8%
2.42
2.48
3.28
1.07
4.88
3.06
6.29
6.21
7.39
8.26
Margins
Gross marginAccelerating
81.9 %▼−0.6 pp ▼−0.6 pp
80.88
80.91
80.80
81.02
82.24
82.53
84.27
82.91
82.52
81.93
Operating marginNot enough history
—— —
Not enough quarters yet to read the trend.Net marginSteady
37.4 %▲+15.7 pp ▲+2.9 pp
23.41
25.58
26.25
8.48
32.59
21.68
36.38
31.72
34.41
37.36
| Metric | Q1 2025Same quarter, prior year | Q4 2025Previous quarter | Q1 2026Latest quarter | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue | $12.73B | $19.29B | $19.80B | +55.5% | +2.6% |
| Cost of revenue | $2.22B | $3.37B | $3.58B | +60.8% | +6.1% |
| Gross profit | $10.50B | $15.92B | $16.22B | +54.4% | +1.9% |
| Operating expenses | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $2.76B | $6.64B | $7.40B | +168% | +11.4% |
| Diluted | $3.06 | $7.39 | $8.26 | +170% | +11.8% |
| Operating cash flow | $1.67B | −$3.19B | $5.33B | +220% | — |
| — | — | — | — | — | |
| Free cash flow | — | — | — | — | — |
| Gross margin | 82.5 % | 82.5 % | 81.9 % | −0.6 pp | −0.6 pp |
| Operating margin | — | — | — | — | — |
| Net margin | 21.7 % | 34.4 % | 37.4 % | +15.7 pp | +2.9 pp |